| Document |
Document Title |
|
WO/2006/066752A1 |
The invention relates to microbicidal hydrophilic polyurethane foams that contain polyhexamethylene biguanide (PHMB) and/or the hydrochloride thereof and a superabsorbent. The invention also relates to wound dressings produced therefrom ...
|
|
WO/2006/065800A2 |
Therapeutic formulations adapted for positive-pressure application for controlling biological fluid at a desired site in a subject, absorbent articles comprising therapeutic formulations, and anti-infective devices coated with therapeuti...
|
|
WO2006037938A9 |
The present invention relates to materials, methods and apparatus for treating a body cavity or passageway. In particular, the invention relates to materials, methods and apparatus for treating a body cavity which has been subjected to s...
|
|
WO/2006/044878A2 |
The present invention is directed to a method of using a multilayered fabric comprising a first absorbable nonwoven fabric and a second absorbable woven or knitted fabric in tissue repair and regeneration.
|
|
WO/2006/044881A2 |
The present invention is directed to a multilayered fabric comprising a first absorbable nonwoven fabric and a second absorbable woven or knitted fabric, and its method of manufacture.
|
|
WO/2006/042169A2 |
Tissue adhesives formed by reacting poly(hydroxylic) compounds derivatized with acetoacetate groups and/or polyamino compounds derivatized with acetoacetamide groups with an amino-functional crosslinking compound are disclosed. The use o...
|
|
WO/2006/042161A2 |
Tissue adhesives formed by reacting an oxidized polysaccharide with a water-dispersible multi-arm polyether amine, wherein at least three of the arms are terminated by primary amine groups, are disclosed. The use of the tissue adhesives ...
|
|
WO/2006/038803A2 |
The invention discloses the use of a liquid composition, capable of promoting the growth of tissue cells at the site of a wound, a process that promotes regeneration of tissue and wound healing. More particularly, the present invention r...
|
|
WO/2006/037606A2 |
The present invention relates to dry and Hydrated, i.e. wet wound dressings and delivery systems also suitable for active ingredients, their use for the treatment of wounds and skin diseases, preferably chronic wounds, and methods of pre...
|
|
WO/2006/036794A1 |
Various embodiments of bulking or cushioning agents or material and related medical devices and methods are disclosed. For example, a method of performing a medical procedure in a tract of a body may include injecting a material in a liq...
|
|
WO/2006/031738A1 |
A method for treating an open wound, such as a surgical wound, may include preparing a first composition including a platelet poor plasma (PPP), and preparing a second composition including a platelet rich plasma (PRP). A layer of the fi...
|
|
WO/2006/030887A1 |
[PROBLEMS] To provide a novel external preparation for treating skin ulcer which exhibits an excellent healing effect on intractable skin ulcer such as bedsore, diabetic skin ulcer or ischemic skin ulcer. [MEANS FOR SOLVING PROBLEMS] An ...
|
|
WO/2006/028364A1 |
A method of preparing a hydrogel wound covering from polymers by irradiation cross-linking is disclosed. An initial aqueous solution comprising at least 15% of a synthetic polymer cross-linkable by irradiation, at least one humectant, a ...
|
|
WO/2006/027657A2 |
The invention relates to a compress for the combined application of natural curatives and electromagnetic rays to the body of a human or an animal. Said compress (1) is made of silicone, rubber, raw rubber, rubber, or a similar plastic m...
|
|
WO/2006/020584A2 |
The present invention is a method of coating an article having a surface. The method includes combining a sparingly soluble silver-containing compound, a solubilizer, and an aqueous solvent, thereby forming a fluid solution. The fluid so...
|
|
WO/2006/010278A1 |
The biocompatible, biodegradable materials in the solid and/or liquid form are based on segmented linear polyurethanes and/or segmented crosslinked polyurethanes based on A) one or more biocompatible polyols susceptible to hydrolytic and...
|
|
WO/2005/118008A2 |
The invention relates to compositions and articles containing s crosslinked polymer matrix and an immobilized active liquid, as well as methods of making and using the same.
|
|
WO/2005/111121A2 |
The object of the invention is to provide a method for producing shaped bodies made from crosslinked gelatine that can be used as substrates for tissue implants and have individually adjustable decomposition periods. The method comprises...
|
|
WO/2005/105115A1 |
A novel composition for use in treating a wound, burn or other skin condition comprises one or more compounds of formula (I), wherein: m = 0-6, n = 6-100, Q, R and R' may be independently selected from, C1-5 alkyl, OU, UOCH2CH3, CH2CH3, ...
|
|
WO/2005/081866A2 |
This invention relates to deployable hemostatic materials comprising chitosan fibers. The hemostatic materials are suitable for use in sealing or controlling active bleeding from artery and vein lacerations and punctures, and for control...
|
|
WO/2005/079878A1 |
This invention relates to bioadhesive compositions, which are particularly, but not exclusively, useful for making medical electrodes and to medical electrodes based on such compositions. A first bioadhesive composition comprises: 10 (i)...
|
|
WO/2005/067991A1 |
A gel for application to a wound, comprising a mixture of citrus complex carbohydrates, a cellulose derivative, a polyol component and water, wherein said citrus complex carbohydrates are cross-linked to said cellulose derivative by an i...
|
|
WO/2005/063311A1 |
The invention relates to therapeutically active wound dressings based on polysaccharides, especially chitosan, and proteins, especially collagen/gelatine, with improved properties. The invention also relates to the production of such dre...
|
|
WO/2005/060550A2 |
Methods of debriding a skin wound are provided. Embodiments of the subject methods include contacting the skin wound with a hydrogel patch debridement composition to debride the wound. Also provided are systems and kits for use in practi...
|
|
WO/2005/058380A1 |
The invention relates to a wound care product that provides a biochemical environment around a wound to promote wound healing. The wound care product includes a keratin protein fraction material in which the protein fraction is intact, i...
|
|
WO/2005/056067A1 |
A silver composition containing sparingly soluble silver compounds and a method of coating the composition on a substrate is disclosed.
|
|
WO/2005/056066A2 |
The present invention provides a medicinal composition comprising water and a Ph-dependent gelling or thickening agent, whereby at 30 °C and pH about 11 the composition is substantially liquid, and at 30 °C and pH about 7 the compositi...
|
|
WO/2005/056070A1 |
A polymer composition that includes a hydrophilic polymer, an optional secondary organic polymer, and a bioactive agent distributed therein, wherein the bioactive agent is selected from the group consisting of a silver compound, a copper...
|
|
WO/2005/055924A2 |
There is disclosed hydrogel compositions comprising a combination of at least two of three components selected from non-acidic poly (N-vinyl lactam), chitosan derivatives and water-soluble multifunctional amine-containing polymers in var...
|
|
WO/2005/054306A1 |
Abstract The present invention relates to a process of making polymerized hydrogels, in particular hydrogel adhesives which e.g. are capable of attaching to mammalian skin and can be used in various personal care products, such as waste-...
|
|
WO/2005/051333A1 |
A patch for covering a portion of the anatomical surface of a living being, said patch being able to adhere to the skin or mucosa, and/or a wound, said patch comprising a backing layer and a layer of a skin-friendly adhesive for adhering...
|
|
WO/2005/041852A2 |
is constituted by keratin gel (1 )and the types 2, 4 and 6 of collagens, for topical use or for lamina preparation (2) use, such as biological dressing with the gel (1) powdered (3) for food and complements use (4), or with the mentioned...
|
|
WO/2005/041811A2 |
This invention relates to deployable hemostatic materials comprising chitosan fibers upon which hemostatic microporous polysaccharide microspheres are deposited. The hemostatic materials are suitable for use in controlling active bleedin...
|
|
WO/2005/042048A2 |
Connective tissue regenerative compositions and methods of repairing and regenerating connective tissue using such compositions are provided. The compositions generally comprise a bioactive hydrogel matrix comprising a polypeptide, such ...
|
|
WO/2005/035012A1 |
A wound dressing for release of one or more therapeutic ingredients wherein the therapeutic ingredients are contained in liposomes, said liposomes may comprising releasing means being triggered by a wound constituent and thereby releasin...
|
|
WO/2005/027993A2 |
The present invention relates generally to the field of hemodialysis, including methods and kits that can be employed to improve hemodialysis therapy. The present invention encompasses methods and kits useful for reducing vascular access...
|
|
WO/2005/027989A1 |
Devices, kits and methods for reducing the risk of infection at an injection or incision site are described herein. The device contains a bioadhesive, biocompatible and bioerodable material and one or more disinfectant agents. In the pre...
|
|
WO/2005/027834A2 |
A composition for promoting the formation of clots in blood comprises a zeolite and a binder. The zeolite is adjusted to have a specific moisture content. Processes by which the moisture content is adjusted include drying, re-hydrating, ...
|
|
WO/2005/025538A1 |
It is intended to provide a composition for medical use which has effects of positively promoting healing of an intractable wound and promoting angiogenesis and tissue regeneration while showing no risk of side effects such as cancerizat...
|
|
WO/2005/025597A1 |
The present invention relates to compositions, including pharmaceutical compositions that promote complement activation, and contain a polypeptide X1-C-X2-X3-X4-X5-X6-X7-X8-C-X9 as described. The invention further relates to a method of ...
|
|
WO/2005/025548A1 |
Topical preparations for release of an active agent to remove necrotic tissue and to methods of making and using the topical preparations are provided. The preparations may have an internal phase dispersed within an external phase. The i...
|
|
WO/2005/023323A1 |
Gelled biopolymer based foams are disclosed. The gelled foams comprise a cross-linked biopolymer, preferably alginate; optionally, a foaming agent such as hydroxy propyl methyl cellulose; and a plasticizer, preferably glycerin sorbitol, ...
|
|
WO/2005/023287A1 |
A vascularization spur composition, incarnant composition and skin ulcer preventive curative composition, comprising a human recombinant HGF having five amino acid residues deleted in the first Kringle domain thereof. The provided compos...
|
|
WO/2005/018695A1 |
A spray-on topical wound debrider spray is prepared forming a mist, spray or foam which will not drip significantly after application. The preferred wound debrider is papain. The spray contains a surfactant emulsifier admixture having a ...
|
|
WO/2005/016116A2 |
The present invention is directed to hemostatic devices comprising a substrate, which substrate comprises a precipitate of a protein in an amount effective to provide hemostatic properties to the substrate, or to maintain and/or improve ...
|
|
WO/2005/009448A1 |
The invented remedy allows cleaning up the area from necrotic tissues and facilitating reduced perifocal oedema and infiltration as well as lessening pain syndrome during suppurative inflammation diseases. The remedy can be applied both ...
|
|
WO/2005/010164A2 |
Polymers that are biocompatible are useful for various medical purposes such as tissue repair, reconstruction and wound healing. A method and composition for producing a biocompatible polymer formed from nucleic acids is disclosed. The n...
|
|
WO/2005/007717A1 |
A process for preparing a thermosensitive polymer from a microemulsion is provided. The microemulsion comprises a monomer capable of forming a thermosensitive polymer and a polymerizable surfactant. Additional comonomers may be included ...
|
|
WO/2005/002510A2 |
This invention relates to deployable hemostatic materials comprising chitosan fibers upon which hemostatic microporous polysaccharide microspheres and a medicament or biologically active substance are deposited. The hemostatic materials ...
|
|
WO/2004/112854A1 |
This invention includes malleable, biodegradable, fibrous compositions for application to a tissue site in order to promote or facilitate new tissue growth. One aspect of this invention is a fibrous component that provides unique mechani...
|
